Lovisa returns to pre-COVID levels on European acquisition

On the back of a European acquisition, Jewellery retailer Lovisa (ASX: LOV) has seen its shares bounce back to levels not seen since the COVID-19 pandemic slamm

N-CSR

Biomedicines, Free Full-Text

AMT - Relations - Development and characterization of the Portable

Class switch toward noninflammatory, spike-specific IgG4

Decellularized diseased tissues: current state‐of‐the‐art and

Frontiers New insights into maladaptive vascular responses to

Evaluation of Intestinal Fibrosis with 68Ga-FAPI PET/MR

Relationship of Tumor Radiation–absorbed Dose to Survival and

N-CSR

Abstracts from the 2022 European Association for Vision and Eye

The gut virome: A new microbiome component in health and disease

Dysregulation of the Kynurenine Pathway, Cytokine Expression

JCM, Free Full-Text

Cerebral hypoperfusion in post-COVID-19 cognitively impaired